Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the class of n‑arylpiperazines, characterized by a quinoxaline core substituted with a trifluoromethyl group and a phenolic moiety. It has been catalogued in chemical and pharmacological databases (e.g., DrugBank, ChEMBL), but there is no evidence of clinical approval or advanced development for any therapeutic indication. Its mechanism of action, biological targets, and potential pharmacological effects are not described in public sources. The compound is considered experimental and has not entered clinical trials as of the latest updates[1][6].
- Other names
- 3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol3-(3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl)phenolQNCYYRHIUFGGJX-UHFFFAOYSA-N
Beyond the preview
Go deeper on 3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol.